SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VGNX -- Variagenics, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (136)4/30/2002 12:55:29 AM
From: scaram(o)uche   of 269
 
this year........

based upon the number of shares issued and outstanding as of April 12, 2002, plus shares of Common Stock subject to options and warrants held by such person on April 12, 2002 exercisable within sixty days thereafter. Except as otherwise indicated, to the knowledge of the Company, all persons listed below have sole voting and investment power with respect to their shares of Common Stock, except to the extent authority is shared by spouses under applicable law.

Name and Address of Beneficial Owner(1)
--------------------------------------------------------------------------------
Number of Shares
Beneficially Owned(2)
--------------------------------------------------------------------------------
Percentage of Shares
Beneficially Owned(2)
--------------------------------------------------------------------------------

Wells Fargo Bank Indiana, N.A.(3)
P.O. Box 960
Fort Wayne, IN 46801 3,419,015 14.4 %
Atlas Venture(4)
222 Berkeley Street, Suite 1950
Boston, MA 02116 2,564,151 10.9 %
Oxford Bioscience Partners(5)
315 Post Road West
Westport, CT 06880 2,092,863 8.9 %
CIBC(6)
425 Lexington Avenue, 9th Floor
New York, NY 10017 2,099,118 9.0 %

14

--------------------------------------------------------------------------------
Forward Ventures(7)
9255 Towne Centre Drive, Suite 300
San Diego, CA 92121 1,242,324 5.3 %
Joseph S. (Jay) Mohr 300 *
Taylor J. Crouch(8) 849,361 3.5 %
Anne L. Bailey(9) 145,811 *
Alan C. Houston, M.D.(10) 74,306 *
Richard P. Shea(11) 125,851 *
Vincent P. Stanton Jr., M.D.(12) 143,219 *
Colin W. Dykes, Ph.D.(13) 296,418 1.3 %
David Housman, Ph.D.(14) 288,391 1.2 %
Philippe O. Chambon, M.D., Ph.D.(15) 3,978,193 16.7 %
Jean-Francois Formela, M.D.(16) 2,595,301 11.0 %
William A. Scott, Ph.D.(17) 29,254 *
Martin A. Vogelbaum(18) 149,584 *
Ellen M. Zane(19) 18,334 *
All directors and current executive officers as a group (11 persons) 7,548,544 30.6 %

--------------------------------------------------------------------------------


last year.......

<CAPTION>
NUMBER OF SHARES PERCENTAGE OF SHARES
NAME AND ADDRESS OF BENEFICIAL OWNER(1) BENEFICIALLY OWNED(2) BENEFICIALLY OWNED(2)
- --------------------------------------- --------------------- ---------------------
<S> <C> <C>
Wells Fargo Bank Indiana, N.A.(3)....................... 3,419,015 14.4%
P.O. Box 960
Fort Wayne, IN 46801

Atlas Venture(4)........................................ 2,564,151 10.9%
222 Berkeley Street, Suite 1950
Boston, MA 02116

Oxford Bioscience Partners(5)........................... 2,115,363 9.0%
315 Post Road West
Westport, CT 06880

CIBC(6)................................................. 2,099,118 9.0%
425 Lexington Avenue, 9th Floor
New York, NY 10017

Forward Ventures(7)..................................... 1,242,324 5.3%
9255 Towne Centre Drive, Suite 300
San Diego, CA 92121

Taylor J. Crouch(8)..................................... 407,798 1.7%

Anne L. Bailey(9)....................................... 100,134 *

Colin W. Dykes, Ph.D.(10)............................... 126,160 *

Bruce L. Maloff, Ph.D.(11).............................. 36,257 *

Richard P. Shea(12)..................................... 79,323 *
</TABLE>

13
<PAGE>

<TABLE>
<CAPTION>
NUMBER OF SHARES PERCENTAGE OF SHARES
NAME AND ADDRESS OF BENEFICIAL OWNER(1) BENEFICIALLY OWNED(2) BENEFICIALLY OWNED(2)
- --------------------------------------- --------------------- ---------------------
<S> <C> <C>
David Housman, Ph.D.(13)................................ 256,619 1.1%

Philippe O. Chambon, M.D., Ph.D.(14).................... 3,965,904 16.8%

Jean-Francois Formela, M.D.(15)......................... 2,582,369 11.0%

William A. Scott, Ph.D.(16)............................. 15,377 *

Martin A. Vogelbaum(17)................................. 40,984 *

Anthony H. Wild, Ph.D.(18).............................. 108,877 *

Ellen M. Zane(19)....................................... 5,000 *

All directors and executive officers as a group (14 7,860,467 31.8%
persons)..............................................
</TABLE>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext